1. FDA Label Klonopin tablets (clonazepam) [approved 6/4/1975, revised Oct 2017] [cited 2023 April 28]
2. O’brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66 Suppl 2:28-33. PMID: 15762817.[cited 2023 April 28]
3. Mattson MP, “Excitotoxins- an overview.” Science Direct [published online, N.D.] [cited 2023 April 28]
4. Almgren M, Källén B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero–influence on head circumference in newborns. Seizure. 2009 Dec;18(10):672-5. doi: 10.1016/j.seizure.2009.09.002. Epub 2009 Oct 13. PMID: 19828334. [cited 2023 April 28]
5. NIDA/NIH authors, “Benzodiazepines and Opioids” [published online 2018 Mar 15] [cited 2023 April 28]
6. “Drug Scheduling” U.S. Drug Enforcement Administration. [published online, N.D.] [cited 2023 April 28]
7. Pétursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994 Nov;89(11):1455-9. doi: 10.1111/j.1360-0443.1994.tb03743.x. PMID: 7841856.[cited 2023 April 28]
8. Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr. 2015;38(5):152-155. doi:10.18773/austprescr.2015.055 [cited 2023 April 28]
9. Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014 Feb;77(2):295-301. doi: 10.1111/j.1365-2125.2012.04418.x. PMID: 22882333; PMCID: PMC4014015. [cited 2023 April 28]
10. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry. 2004;65 Suppl 5:7-12. PMID: 15078112. [cited 2023 April 28]
11. Nelson J, Chouinard G. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology. Can J Clin Pharmacol. 1999 Summer;6(2):69-83. PMID: 10519733. [cited 2023 April 28]
12. Pimlott NJ, Hux JE, Wilson LM, Kahan M, Li C, Rosser WW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ. 2003 Apr 1;168(7):835-9. PMID: 12668540; PMCID: PMC151988. [cited 2023 April 28]
13. FDA Drug Information: Benzodiazepines [published online Sept 23 2020] [cited 2023 April 28]
14. FDA label Xanax (revised 20160 [cited 2023 April 28]
15. DEA Fact Sheet, “Benzodiazepines: Street Names” [online] December 2019 [cited 2023 April 28]
16. Dept. Consumer Protection, “Clonazepam” fact sheet [online] N.D.[cited 2023 April 28]
17. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. 1994 Jul;48(1):25-40. doi: 10.2165/00003495-199448010-00004. PMID: 7525193. [cited 2023 April 28]
18. Lader M. Short-term versus long-term benzodiazepine therapy. Curr Med Res Opin. 1984;8 Suppl 4:120-6. doi: 10.1185/03007998409109550. PMID: 6144459. [cited 2023 April 28]
19. Ashton, H, “The Ashton Manual” [as published online] [cited 2023 April 28]
20. Laskey C, Opitz B. Tinnitus associated with benzodiazepine withdrawal syndrome: A case report and literature review. Ment Health Clin. 2020;10(3):100-103. Published 2020 May 7. doi:10.9740/mhc.2020.05.100 [cited 2023 April 28]
21. Bounds CG, Nelson VL. Benzodiazepines. [Updated 2020 Nov 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470159/ [cited 2023 April 28]
22. Tapiainen V, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. The risk of Alzheimer’s disease associated with benzodiazepines and related drugs: a nested case-control study. Acta Psychiatr Scand. 2018 Aug;138(2):91-100. doi: 10.1111/acps.12909. Epub 2018 May 31. PMID: 29851063. [cited 2023 April 28]
23. Rajamaki B, Hartikainen S, Tolppanen AM. Psychotropic Drug-Associated Pneumonia in Older Adults. Drugs Aging. 2020 Apr;37(4):241-261. doi: 10.1007/s40266-020-00754-1. PMID: 32107741; PMCID: PMC7096389. [cited 2023 April 28]
24. Haefely W. Benzodiazepine interactions with GABA receptors. Neurosci Lett. 1984 Jun 29;47(3):201-6. doi: 10.1016/0304-3940(84)90514-7. PMID: 6147796. [cited 2023 April 28]
25. Petit J, Sansone RA. A case of interdose discontinuation symptoms with venlafaxine extended release. Prim Care Companion CNS Disord. 2011;13(5):PCC.11l01140. doi:10.4088/PCC.11l01140 [cited 2023 April 28]
26. NIH, “Benzodiazepines and Opioids” [information letter published online] [cited 2023 April 28]
27. Welch TR, Rumack BH, Hammond K. Clonazepam overdose resulting in cyclic coma. Clin Toxicol. 1977;10(4):433-6. doi: 10.3109/15563657709046280. PMID: 862377. [cited 2023 April 28]
28. Brown JS Jr. Psychiatric issues in toxic exposures. Psychiatr Clin North Am. 2007 Dec;30(4):837-54. doi: 10.1016/j.psc.2007.07.004. PMID: 17938048. [cited 2023 April 28]
29. Costa LG, Giordano G, Guizzetti M, Vitalone A. Neurotoxicity of pesticides: a brief review. Front Biosci. 2008 Jan 1;13:1240-9. doi: 10.2741/2758. PMID: 17981626.[cited 2023 April 28]
30. Choudhary AK, Lee YY. Neurophysiological symptoms and aspartame: What is the connection? Nutr Neurosci. 2018 Jun;21(5):306-316. doi: 10.1080/1028415X.2017.1288340. Epub 2017 Feb 15. PMID: 28198207. [cited 2023 April 28]
31. Basit H, Kahwaji CI. Clonazepam. [Updated 2021 Dec 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556010/ [cited 2023 April 28]
32. Alicja Lerner, Michael Klein, Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development, Brain Communications, Volume 1, Issue 1, 2019, fcz025 [cited 2023 April 28]
33. Dokkedal-Silva V, Berro LF, Galduróz JCF, Tufik S, Andersen ML. Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use. Harv Rev Psychiatry. 2019 Sep/Oct;27(5):279-289. doi: 10.1097/HRP.0000000000000227. PMID: 31385811. [cited 2023 April 28]
34. Balaram K, Marwaha R. Agoraphobia. 2022 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32119274.[cited 2023 April 28]
35. Citkowska-Kisielewska A, Rutkowski K, Sobański JA, Dembińska E, Mielimąka M. Anxiety symptoms in obsessive-compulsive disorder and generalized anxiety disorder. Psychiatr Pol. 2019 Aug 31;53(4):845-864. English, Polish. doi: 10.12740/PP/105378. Epub 2019 Aug 31. PMID: 31760413.[cited 2023 April 28]
36. Roche Product Monograph Rivotril (clonazepam) [approval revised July 5, 2021] [cited 2023 April 28]
37. Kharadi D, Patel K, Rana D, Patel V. Off-label drug use in Psychiatry Outpatient Department: A prospective study at a Tertiary Care Teaching Hospital. J Basic Clin Pharm. 2015 Mar;6(2):45-9. doi: 10.4103/0976-0105.152090. PMID: 25767363; PMCID: PMC4356999. [cited 2023 April 28]
38. Shakeel S, Nesar S, Rehman H, Jamil K, Mallick IA, Mustafa MS, Anwar M, Jamshed S. Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study. Pharmacy (Basel). 2021 Dec 20;9(4):203. doi: 10.3390/pharmacy9040203. PMID: 34941635; PMCID: PMC8703660. [cited 2023 April 28]
39. Revet A, Yrondi A, Montastruc F. Règles de bon usage des benzodiazépines [Good practices in prescribing benzodiazepines]. Presse Med. 2018 Oct;47(10):872-877. French. doi: 10.1016/j.lpm.2018.10.008. Epub 2018 Oct 29. PMID: 30385184. [cited 2023 April 28]